Industrial Policy for Biotechnology and Biomanufacturing

Panelists could engage on what U.S. policies that are currently in place could be considered industrial policy for biotech and the current biopolicy landscape, what further policies could be put in place to support the biotech sector, how industrial policy for biotech has worked for other countries (or how industrial policy has worked in other U.S. sectors), and how the synbiobeta community can engage in shaping U.S. biotech policymaking or implementation. - Panelists could be folks like, for example (none have been asked yet): Mary Maxon or Andrea Hodgson; Michelle Rozo; Dahlia Sokolov; Patrick Boyle; Emily Leproust; Doug Friedman; David Markowitz